BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23229602)

  • 1. [Uric acid and the prevention of renal and cardiovascular disease in CKD].
    Teatini U
    G Ital Nefrol; 2012; 29 Suppl 58():S46-8. PubMed ID: 23229602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
    Kanellis J; Feig DI; Johnson RJ
    Nephrology (Carlton); 2004 Dec; 9(6):394-9. PubMed ID: 15663643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uric acid, the kidney and cardiovascular mortality].
    Santoro A; Mandreoli M
    G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease.
    Nakagawa T; Kang DH; Feig D; Sanchez-Lozada LG; Srinivas TR; Sautin Y; Ejaz AA; Segal M; Johnson RJ
    Kidney Int; 2006 May; 69(10):1722-5. PubMed ID: 16598194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid and chronic kidney disease: new understanding of an old problem.
    Kang DH; Chen W
    Semin Nephrol; 2011 Sep; 31(5):447-52. PubMed ID: 22000652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid, the metabolic syndrome, and renal disease.
    Cirillo P; Sato W; Reungjui S; Heinig M; Gersch M; Sautin Y; Nakagawa T; Johnson RJ
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S165-8. PubMed ID: 17130256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.
    Zawiasa A; Nowicki M
    Metabolism; 2013 Oct; 62(10):1462-9. PubMed ID: 23866980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered uric acid levels and disease states.
    Kutzing MK; Firestein BL
    J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posing the question again: does chronic uric acid nephropathy exist?
    Moe OW
    J Am Soc Nephrol; 2010 Mar; 21(3):395-7. PubMed ID: 19729442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference.
    McCullough PA; Haapio M; Mankad S; Zamperetti N; Massie B; Bellomo R; Berl T; Anker SD; Anand I; Aspromonte N; Bagshaw SM; Bobek I; Cruz DN; Daliento L; Davenport A; Hillege H; House AA; Katz N; Maisel A; Mebazaa A; Palazzuoli A; Ponikowski P; Ronco F; Shaw A; Sheinfeld G; Soni S; Vescovo G; Zanco P; Ronco C; Berl T;
    Nephrol Dial Transplant; 2010 Jun; 25(6):1777-84. PubMed ID: 20375030
    [No Abstract]   [Full Text] [Related]  

  • 12. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal diseases in disturbance of urate metabolism].
    Tofuku Y
    Nihon Rinsho; 1995 Aug; 53(8):1988-94. PubMed ID: 7563639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricaemia: more than just a cause of gout?
    Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric Acid as a Marker of Kidney Disease: Review of the Current Literature.
    Giordano C; Karasik O; King-Morris K; Asmar A
    Dis Markers; 2015; 2015():382918. PubMed ID: 26106252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uric acid and cardiorenal risk: marker or cause?].
    Bellomo G; Venanzi S; Timio M
    G Ital Nefrol; 2011; 28(2):157-65. PubMed ID: 21488030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uric acid--more deleterious than we thought?].
    Høieggen A; Os I; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2005 May; 125(10):1330-2. PubMed ID: 15909004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid--a uremic toxin?
    Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ
    Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.